{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:39Z","timestamp":1794651399997,"version":"4.9.1"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0520303"],"award-info":[{"award-number":["2024ZD0520303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02969-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:11:54Z","timestamp":1781795514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications"],"prefix":"10.1186","volume":"24","author":[{"given":"Guanhua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2969_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659\u2013702.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2969_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10456-016-9509-6","volume":"19","author":"ME Ziegler","year":"2016","unstructured":"Ziegler ME, Hatch MMS, Wu N, Muawad SA, Hughes CCW. mTORC2 mediates CXCL12-induced angiogenesis. Angiogenesis. 2016;19(3):359\u201371.","journal-title":"Angiogenesis"},{"issue":"11","key":"2969_CR3","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1002\/cam4.3014","volume":"9","author":"H Liu","year":"2020","unstructured":"Liu H, Yang Z, Lu W, Chen Z, Chen L, Han S, et al. Chemokines and chemokine receptors: A new strategy for breast cancer therapy. Cancer Med. 2020;9(11):3786\u201399.","journal-title":"Cancer Med"},{"issue":"12","key":"2969_CR4","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s00262-021-02944-1","volume":"70","author":"T Fan","year":"2021","unstructured":"Fan T, Liu Y, Liu H, Wang L, Tian H, Zheng Y, et al. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma. Cancer Immunol Immunother. 2021;70(12):3651\u201367.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"2969_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.18632\/aging.202269","volume":"13","author":"T Fan","year":"2020","unstructured":"Fan T, Zhu M, Wang L, Liu Y, Tian H, Zheng Y, et al. Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma. Aging. 2020;13(2):2397\u2013417.","journal-title":"Aging"},{"issue":"6","key":"2969_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.186.6.825","volume":"186","author":"CA Power","year":"1997","unstructured":"Power CA, Church DJ, Meyer A, Alouani S, Proudfoot AE, Clark-Lewis I, et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med. 1997;186(6):825\u201335.","journal-title":"J Exp Med"},{"issue":"6","key":"2969_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.186.6.837","volume":"186","author":"DR Greaves","year":"1997","unstructured":"Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med. 1997;186(6):837\u201344.","journal-title":"J Exp Med"},{"issue":"2","key":"2969_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1172\/JCI118107","volume":"96","author":"WA Border","year":"1995","unstructured":"Border WA, Noble NA. Fibrosis linked to TGF-beta in yet another disease. J Clin Invest. 1995;96(2):655\u20136.","journal-title":"J Clin Invest"},{"issue":"1","key":"2969_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/eji.200636251","volume":"37","author":"T Kondo","year":"2007","unstructured":"Kondo T, Takata H, Takiguchi M. Functional expression of chemokine receptor CCR6 on human effector memory CD8\u2009+\u2009T cells. Eur J Immunol. 2007;37(1):54\u201365.","journal-title":"Eur J Immunol"},{"issue":"7","key":"2969_CR10","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1182\/blood.V96.7.2338","volume":"96","author":"R Krzysiek","year":"2000","unstructured":"Krzysiek R, Lefevre EA, Bernard J, Foussat A, Galanaud P, Louache F, et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha\/CCL20 in human B cells. Blood. 2000;96(7):2338\u201345.","journal-title":"Blood"},{"issue":"12","key":"2969_CR11","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.4049\/jimmunol.181.12.8391","volume":"181","author":"T Yamazaki","year":"2008","unstructured":"Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol. 2008;181(12):8391\u2013401.","journal-title":"J Immunol"},{"issue":"2","key":"2969_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","volume":"24","author":"M Le Borgne","year":"2006","unstructured":"Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8\u2009+\u2009T cell crosspriming in vivo. Immunity. 2006;24(2):191\u2013201.","journal-title":"Immunity"},{"issue":"2","key":"2969_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/mi.2008.84","volume":"2","author":"C Wang","year":"2009","unstructured":"Wang C, Kang SG, Lee J, Sun Z, Kim CH. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol. 2009;2(2):173\u201383.","journal-title":"Mucosal Immunol"},{"issue":"suppl2","key":"2969_CR14","doi-asserted-by":"publisher","first-page":"S641","DOI":"10.1093\/ecco-jcc\/jjx145","volume":"12","author":"PJ Trivedi","year":"2018","unstructured":"Trivedi PJ, Adams DH. Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise. J Crohns Colitis. 2018;12(suppl2):S641\u201352.","journal-title":"J Crohns Colitis"},{"issue":"12","key":"2969_CR15","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204(12):2803\u201312.","journal-title":"J Exp Med"},{"issue":"6","key":"2969_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng.583","volume":"42","author":"Y Kochi","year":"2010","unstructured":"Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, Takahashi A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet. 2010;42(6):515\u20139.","journal-title":"Nat Genet"},{"issue":"4","key":"2969_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2020.10.094","volume":"84","author":"YA Elnabawi","year":"2021","unstructured":"Elnabawi YA, Garshick MS, Tawil M, Barrett TJ, Fisher EA, Lo Sicco K, et al. CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health. J Am Acad Dermatol. 2021;84(4):913\u201320.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2969_CR18","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1172\/JCI37378","volume":"119","author":"MN Hedrick","year":"2009","unstructured":"Hedrick MN, Lonsdorf AS, Shirakawa A-K, Richard Lee C-C, Liao F, Singh SP, et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest. 2009;119(8):2317\u201329.","journal-title":"J Clin Invest"},{"key":"2969_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaut.2017.10.013","volume":"88","author":"N Kulkarni","year":"2018","unstructured":"Kulkarni N, Meitei HT, Sonar SA, Sharma PK, Mujeeb VR, Srivastava S, et al. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation. J Autoimmun. 2018;88:121\u201330.","journal-title":"J Autoimmun"},{"issue":"3","key":"2969_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/2013.jamaneurol.409","volume":"70","author":"L Schirmer","year":"2013","unstructured":"Schirmer L, Rothhammer V, Hemmer B, Korn T. Enriched CD161high CCR6\u2009+\u2009\u03b3\u03b4 T cells in the cerebrospinal fluid of patients with multiple sclerosis. JAMA Neurol. 2013;70(3):345\u201351.","journal-title":"JAMA Neurol"},{"issue":"Pt 3","key":"2969_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.semcancer.2022.02.007","volume":"86","author":"S-N Jia","year":"2022","unstructured":"Jia S-N, Han Y-B, Yang R, Yang Z-C. Chemokines in colon cancer progression. Semin Cancer Biol. 2022;86(Pt 3):400\u20137.","journal-title":"Semin Cancer Biol"},{"key":"2969_CR22","doi-asserted-by":"crossref","unstructured":"Kadomoto S, Izumi K, Mizokami A. The CCL20-CCR6 Axis in Cancer Progression. Int J Mol Sci. 2020;21(15) :5186.","DOI":"10.3390\/ijms21155186"},{"issue":"1","key":"2969_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s40425-019-0701-2","volume":"7","author":"D Wang","year":"2019","unstructured":"Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, et al. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1\/CEBPB\/NF-\u03baB signaling. J Immunother Cancer. 2019;7(1):215.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"2969_CR24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/abbs\/gmw101","volume":"48","author":"B Liu","year":"2016","unstructured":"Liu B, Jia Y, Ma J, Wu S, Jiang H, Cao Y, et al. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer. Acta Biochim Biophys Sin (Shanghai). 2016;48(12):1067\u201374.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"7","key":"2969_CR25","doi-asserted-by":"publisher","first-page":"102846","DOI":"10.1016\/j.autrev.2021.102846","volume":"20","author":"HT Meitei","year":"2021","unstructured":"Meitei HT, Jadhav N, Lal G. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Autoimmun Rev. 2021;20(7):102846.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2969_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/icb.2013.97","volume":"92","author":"AYS Lee","year":"2014","unstructured":"Lee AYS, K\u00f6rner H. CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis. Immunol Cell Biol. 2014;92(4):354\u20138.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"2969_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/geno.2001.6482","volume":"73","author":"RT Nelson","year":"2001","unstructured":"Nelson RT, Boyd J, Gladue RP, Paradis T, Thomas R, Cunningham AC, et al. Genomic organization of the CC chemokine mip-3alpha\/CCL20\/larc\/exodus\/SCYA20, showing gene structure, splice variants, and chromosome localization. Genomics. 2001;73(1):28\u201337.","journal-title":"Genomics"},{"issue":"3","key":"2969_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.4049\/jimmunol.158.3.1033","volume":"158","author":"DL Rossi","year":"1997","unstructured":"Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol. 1997;158(3):1033\u20136.","journal-title":"J Immunol"},{"issue":"9","key":"2969_CR29","first-page":"3315","volume":"89","author":"R Hromas","year":"1997","unstructured":"Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K, et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood. 1997;89(9):3315\u201322.","journal-title":"Blood"},{"issue":"8","key":"2969_CR30","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.4049\/jimmunol.165.8.4470","volume":"165","author":"E Schutyser","year":"2000","unstructured":"Schutyser E, Struyf S, Menten P, Lenaerts JP, Conings R, Put W, et al. Regulated production and molecular diversity of human liver and activation-regulated chemokine\/macrophage inflammatory protein-3 alpha from normal and transformed cells. J Immunol. 2000;165(8):4470\u20137.","journal-title":"J Immunol"},{"issue":"40","key":"2969_CR31","doi-asserted-by":"publisher","first-page":"37647","DOI":"10.1074\/jbc.M203907200","volume":"277","author":"DM Hoover","year":"2002","unstructured":"Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, et al. The structure of human macrophage inflammatory protein-3alpha \/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem. 2002;277(40):37647\u201354.","journal-title":"J Biol Chem"},{"issue":"5","key":"2969_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.yexcr.2010.12.018","volume":"317","author":"T Ito","year":"2011","unstructured":"Ito T, Carson WF, Cavassani KA, Connett JM, Kunkel SL. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res. 2011;317(5):613\u20139.","journal-title":"Exp Cell Res"},{"issue":"3","key":"2969_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.imbio.2019.01.005","volume":"224","author":"AYS Lee","year":"2019","unstructured":"Lee AYS, K\u00f6rner H. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology. Immunobiology. 2019;224(3):449\u201354.","journal-title":"Immunobiology"},{"issue":"5","key":"2969_CR34","doi-asserted-by":"publisher","first-page":"e97566","DOI":"10.1371\/journal.pone.0097566","volume":"9","author":"B Nandi","year":"2014","unstructured":"Nandi B, Pai C, Huang Q, Prabhala RH, Munshi NC, Gold JS. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS ONE. 2014;9(5):e97566.","journal-title":"PLoS ONE"},{"issue":"7","key":"2969_CR35","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/1521-4141(200107)31:7<1981::AID-IMMU1981>3.0.CO;2-X","volume":"31","author":"P Scapini","year":"2001","unstructured":"Scapini P, Laudanna C, Pinardi C, Allavena P, Mantovani A, Sozzani S, et al. Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)\/CCL20 and MIP-3beta\/CCL19. Eur J Immunol. 2001;31(7):1981\u20138.","journal-title":"Eur J Immunol"},{"issue":"5","key":"2969_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","volume":"14","author":"E Schutyser","year":"2003","unstructured":"Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14(5):409\u201326.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2969_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2334-14-354","volume":"14","author":"S Islam","year":"2014","unstructured":"Islam S, Kanbe K, Shimizu N, Ohtsuki T, Jinno-Oue A, Tanaka A, et al. CKR-L3, a deletion version CCR6-isoform shows coreceptor-activity for limited human and simian immunodeficiency viruses. BMC Infect Dis. 2014;14:354.","journal-title":"BMC Infect Dis"},{"key":"2969_CR38","doi-asserted-by":"crossref","unstructured":"Jones AJY, Gabriel F, Tandale A, Nietlispach D. Structure and Dynamics of GPCRs in Lipid Membranes: Physical Principles and Experimental Approaches. Molecules. 2020;25(20) :4729.","DOI":"10.3390\/molecules25204729"},{"issue":"1","key":"2969_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1124\/jpet.116.237669","volume":"360","author":"B Julian","year":"2017","unstructured":"Julian B, Gao K, Harwood BN, Beinborn M, Kopin AS. Mutation-Induced Functional Alterations of CCR6. J Pharmacol Exp Ther. 2017;360(1):106\u201316.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2969_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","volume":"6","author":"D Yang","year":"2021","unstructured":"Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y, et al. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther. 2021;6(1):7.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2969_CR41","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1038\/emm.2015.105","volume":"48","author":"M Jo","year":"2016","unstructured":"Jo M, Jung ST. Engineering therapeutic antibodies targeting G-protein-coupled receptors. Exp Mol Med. 2016;48(2):e207.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2969_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1124\/pr.111.005074","volume":"65","author":"GE White","year":"2013","unstructured":"White GE, Iqbal AJ, Greaves DR. CC chemokine receptors and chronic inflammation\u2013therapeutic opportunities and pharmacological challenges. Pharmacol Rev. 2013;65(1):47\u201389.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2969_CR43","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1038\/s41467-020-16820-6","volume":"11","author":"DJ Wasilko","year":"2020","unstructured":"Wasilko DJ, Johnson ZL, Ammirati M, Che Y, Griffor MC, Han S, et al. Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20. Nat Commun. 2020;11(1):3031.","journal-title":"Nat Commun"},{"issue":"5","key":"2969_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1074-7613(00)80201-0","volume":"12","author":"DN Cook","year":"2000","unstructured":"Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity. 2000;12(5):495\u2013503.","journal-title":"Immunity"},{"issue":"6","key":"2969_CR45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8(6):639\u201346.","journal-title":"Nat Immunol"},{"issue":"12","key":"2969_CR46","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/bjc.2016.113","volume":"114","author":"N Kapur","year":"2016","unstructured":"Kapur N, Mir H, Clark Iii CE, Krishnamurti U, Beech DJ, Lillard JW, et al. CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition. Br J Cancer. 2016;114(12):1343\u201351.","journal-title":"Br J Cancer"},{"issue":"7","key":"2969_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12094-015-1420-x","volume":"18","author":"XG Zhang","year":"2016","unstructured":"Zhang XG, Song BT, Liu FJ, Sun D, Wang KX, Qu H. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Clin Transl Oncol. 2016;18(7):700\u20137.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"2969_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/cei.13233","volume":"195","author":"M Lyu","year":"2019","unstructured":"Lyu M, Li Y, Hao Y, Lyu C, Huang Y, Sun B, et al. CCR6 defines a subset of activated memory T cells of Th17 potential in immune thrombocytopenia. Clin Exp Immunol. 2019;195(3):345\u201357.","journal-title":"Clin Exp Immunol"},{"key":"2969_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm AE, Richmond A. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy. Front Immunol. 2019;10:333.","journal-title":"Front Immunol"},{"key":"2969_CR50","doi-asserted-by":"crossref","unstructured":"Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Int J Mol Sci. 2020;21(20):7619 .","DOI":"10.3390\/ijms21207619"},{"key":"2969_CR51","doi-asserted-by":"publisher","first-page":"688066","DOI":"10.3389\/fimmu.2021.688066","volume":"12","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Yang G, Xiao F, Xie J, Wang S, Lu L, et al. Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases. Front Immunol. 2021;12:688066.","journal-title":"Front Immunol"},{"issue":"5","key":"2969_CR52","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54(5):859\u201374.","journal-title":"Immunity"},{"issue":"4","key":"2969_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/emm.2005.40","volume":"37","author":"H-J Lee","year":"2005","unstructured":"Lee H-J, Choi S-C, Choi E-Y, Lee M-H, Seo G-S, Kim E-C, et al. Iron chelator induces MIP-alpha\/CCL20 in human intestinal epithelial cells: implication for triggering mucosal adaptive immunity. Exp Mol Med. 2005;37(4):297\u2013310.","journal-title":"Exp Mol Med"},{"issue":"10","key":"2969_CR54","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/intimm\/13.10.1255","volume":"13","author":"S Fujiie","year":"2001","unstructured":"Fujiie S, Hieshima K, Izawa D, Nakayama T, Fujisawa R, Ohyanagi H, et al. Proinflammatory cytokines induce liver and activation-regulated chemokine\/macrophage inflammatory protein-3alpha\/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB]. Int Immunol. 2001;13(10):1255\u201363.","journal-title":"Int Immunol"},{"key":"2969_CR55","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3389\/fimmu.2017.01871","volume":"8","author":"AYS Lee","year":"2017","unstructured":"Lee AYS, Reimer D, Zehrer A, Lu M, Mielenz D, K\u00f6rner H. Expression of Membrane-Bound CC Chemokine Ligand 20 on Follicular T Helper Cells in T-B-Cell Conjugates. Front Immunol. 2017;8:1871.","journal-title":"Front Immunol"},{"issue":"6","key":"2969_CR56","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.4049\/jimmunol.1203310","volume":"192","author":"M Paradis","year":"2014","unstructured":"Paradis M, Mindt BC, Duerr CU, Rojas OL, Ng D, Boulianne B, et al. A TNF-\u03b1-CCL20-CCR6 axis regulates Nod1-induced B cell responses. J Immunol. 2014;192(6):2787\u201399.","journal-title":"J Immunol"},{"key":"2969_CR57","doi-asserted-by":"crossref","unstructured":"Renaude E, Kroemer M, Loyon R, Binda D, Borg C, Guittaut M et al. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment. Int J Mol Sci. 2020;21(5) :1673.","DOI":"10.3390\/ijms21051673"},{"key":"2969_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biopha.2018.09.037","volume":"108","author":"C Mo","year":"2018","unstructured":"Mo C, Zeng Z, Deng Q, Ding Y, Xiao R. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis. Biomed Pharmacother. 2018;108:177\u201383.","journal-title":"Biomed Pharmacother"},{"key":"2969_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbrc.2022.11.088","volume":"641","author":"N Sachi","year":"2023","unstructured":"Sachi N, Kamiyama N, Saechue B, Ozaka S, Dewayani A, Ariki S, et al. CCL20\/CCR6 chemokine signaling is not essential for pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochem Biophys Res Commun. 2023;641:123\u201331.","journal-title":"Biochem Biophys Res Commun"},{"key":"2969_CR60","doi-asserted-by":"publisher","first-page":"590409","DOI":"10.1155\/2014\/590409","volume":"2014","author":"DW Wojkowska","year":"2014","unstructured":"Wojkowska DW, Szpakowski P, Ksiazek-Winiarek D, Leszczynski M, Glabinski A. Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis. Mediators Inflamm. 2014;2014:590409.","journal-title":"Mediators Inflamm"},{"key":"2969_CR61","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.gene.2018.11.006","volume":"685","author":"FZ El Sharkawi","year":"2019","unstructured":"El Sharkawi FZ, Ali SA, Hegazy MI, Atya HB. The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt. Gene. 2019;685:164\u20139.","journal-title":"Gene"},{"issue":"1","key":"2969_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. Pathogenic conversion of Foxp3\u2009+\u2009T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20(1):62\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"2969_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jcp.21839","volume":"221","author":"G Lisignoli","year":"2009","unstructured":"Lisignoli G, Manferdini C, Codeluppi K, Piacentini A, Grassi F, Cattini L, et al. CCL20\/CCR6 chemokine\/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups. J Cell Physiol. 2009;221(1):154\u201360.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2969_CR64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13075-019-1984-x","volume":"21","author":"A Takaki-Kuwahara","year":"2019","unstructured":"Takaki-Kuwahara A, Arinobu Y, Miyawaki K, Yamada H, Tsuzuki H, Irino K, et al. CCR6\u2009+\u2009group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines. Arthritis Res Ther. 2019;21(1):198.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2969_CR65","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/jcp.20905","volume":"210","author":"G Lisignoli","year":"2007","unstructured":"Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, et al. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. J Cell Physiol. 2007;210(3):798\u2013806.","journal-title":"J Cell Physiol"},{"key":"2969_CR66","doi-asserted-by":"crossref","unstructured":"Mabuchi T, Chang TW, Quinter S, Hwang ST. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci. 2012;65(1) :4-11.","DOI":"10.1016\/j.jdermsci.2011.11.007"},{"issue":"9","key":"2969_CR67","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1517\/14728222.2010.504716","volume":"14","author":"MN Hedrick","year":"2010","unstructured":"Hedrick MN, Lonsdorf AS, Hwang ST, Farber JM. CCR6 as a possible therapeutic target in psoriasis. Expert Opin Ther Targets. 2010;14(9):911\u201322.","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"2969_CR68","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","volume":"129","author":"EG Harper","year":"2009","unstructured":"Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol. 2009;129(9):2175\u201383.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2969_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1023\/B:JOCI.0000018066.46279.6b","volume":"24","author":"A Kaser","year":"2004","unstructured":"Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, et al. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol. 2004;24(1):74\u201385.","journal-title":"J Clin Immunol"},{"issue":"11","key":"2969_CR70","doi-asserted-by":"publisher","first-page":"e0141710","DOI":"10.1371\/journal.pone.0141710","volume":"10","author":"HK Skovdahl","year":"2015","unstructured":"Skovdahl HK, Granlund AB, \u00d8stvik AE, Bruland T, Bakke I, Torp SH, et al. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells. PLoS ONE. 2015;10(11):e0141710.","journal-title":"PLoS ONE"},{"key":"2969_CR71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fimmu.2013.00194","volume":"4","author":"AYS Lee","year":"2013","unstructured":"Lee AYS, Eri R, Lyons AB, Grimm MC, Korner H. CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil? Front Immunol. 2013;4:194.","journal-title":"Front Immunol"},{"key":"2969_CR72","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.biopha.2016.11.055","volume":"85","author":"E Lu","year":"2017","unstructured":"Lu E, Su J, Zhou Y, Zhang C, Wang Y. CCL20\/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway. Biomed Pharmacother. 2017;85:486\u201392.","journal-title":"Biomed Pharmacother"},{"issue":"23","key":"2969_CR73","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1038\/s41388-018-0182-7","volume":"37","author":"P Jin","year":"2018","unstructured":"Jin P, Shin S-H, Chun Y-S, Shin H-W, Shin YJ, Lee Y, et al. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-\u03baB signaling pathway. Oncogene. 2018;37(23):3070\u201387.","journal-title":"Oncogene"},{"key":"2969_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2019.12.024","volume":"472","author":"W Liu","year":"2020","unstructured":"Liu W, Wang W, Wang X, Xu C, Zhang N, Di W. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis. Cancer Lett. 2020;472:59\u201369.","journal-title":"Cancer Lett"},{"key":"2969_CR75","doi-asserted-by":"publisher","first-page":"12739","DOI":"10.2147\/OTT.S280309","volume":"13","author":"W Liu","year":"2020","unstructured":"Liu W, Wang W, Zhang N, Di W. The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis. Onco Targets Ther. 2020;13:12739\u201350.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2969_CR76","doi-asserted-by":"publisher","first-page":"114385","DOI":"10.1016\/j.isci.2025.114385","volume":"29","author":"HT Meitei","year":"2026","unstructured":"Meitei HT, Kulkarni N, Shirolkar A, Rapole S, Sharma PK, Mujeeb VR, et al. CCL20-CCR6 signaling alters the metabolic reprogramming to promote the pathogenic Th17 cell differentiation. iScience. 2026;29(1):114385.","journal-title":"iScience"},{"issue":"11","key":"2969_CR77","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2326-6066.CIR-24-0230","volume":"12","author":"A Pant","year":"2024","unstructured":"Pant A, Jain A, Chen Y, Patel K, Saleh L, Tzeng S, et al. The CCR6-CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors. Cancer Immunol Res. 2024;12(11):1542\u201358.","journal-title":"Cancer Immunol Res"},{"key":"2969_CR78","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Melero S, Caballero-Villarraso J. CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases. Antibodies (Basel). 2023;12(2) :30.","DOI":"10.3390\/antib12020030"},{"key":"2969_CR79","doi-asserted-by":"crossref","unstructured":"Cartes-Vel\u00e1squez R, Vera A, Torres-Quevedo R, Medrano-D\u00edaz J, P\u00e9rez A, Mu\u00f1oz C et al. The Immunomodulatory Role of Vitamin D in Regulating the Th17\/Treg Balance and Epithelial-Mesenchymal Transition: A Hypothesis for Gallbladder Cancer. Nutrients. 2024;16(23) :6134.","DOI":"10.3390\/nu16234134"},{"issue":"3","key":"2969_CR80","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3892\/or.2013.2570","volume":"30","author":"Q Li","year":"2013","unstructured":"Li Q, Li Q, Chen J, Liu Y, Zhao X, Tan B, et al. Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep. 2013;30(3):1215\u201322.","journal-title":"Oncol Rep"},{"issue":"10","key":"2969_CR81","doi-asserted-by":"publisher","first-page":"845","DOI":"10.5306\/wjco.v12.i10.845","volume":"12","author":"HS Marques","year":"2021","unstructured":"Marques HS, de Brito BB, da Silva FAF, Santos MLC, de Souza JCB, Correia TML, et al. Relationship between Th17 immune response and cancer. World J Clin Oncol. 2021;12(10):845\u201367.","journal-title":"World J Clin Oncol"},{"issue":"1","key":"2969_CR82","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4049\/jimmunol.162.1.186","volume":"162","author":"F Liao","year":"1999","unstructured":"Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol. 1999;162(1):186\u201394.","journal-title":"J Immunol"},{"issue":"6","key":"2969_CR83","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/ng.582","volume":"42","author":"EA Stahl","year":"2010","unstructured":"Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42(6):508\u201314.","journal-title":"Nat Genet"},{"issue":"11","key":"2969_CR84","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1111\/jcmm.13783","volume":"22","author":"M Bonelli","year":"2018","unstructured":"Bonelli M, Puchner A, G\u00f6schl L, Hayer S, Niederreiter B, Steiner G, et al. CCR6 controls autoimmune but not innate immunity-driven experimental arthritis. J Cell Mol Med. 2018;22(11):5278\u201385.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2969_CR85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2249.2001.01542.x","volume":"125","author":"T Matsui","year":"2001","unstructured":"Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, Rana M, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol. 2001;125(1):155\u201361.","journal-title":"Clin Exp Immunol"},{"key":"2969_CR86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.imlet.2020.11.005","volume":"229","author":"W Liu","year":"2021","unstructured":"Liu W, Zhou X, Wang A, Ma J, Bai Y. Increased peripheral helper T cells type 17 subset correlates with the severity of psoriasis vulgaris. Immunol Lett. 2021;229:48\u201354.","journal-title":"Immunol Lett"},{"key":"2969_CR87","doi-asserted-by":"publisher","first-page":"8065147","DOI":"10.1155\/2020\/8065147","volume":"2020","author":"C Aguilar-Flores","year":"2020","unstructured":"Aguilar-Flores C, Castro-Escamilla O, Ortega-Rocha EM, Maldonado-Garc\u00eda C, Jurado-Santa Cruz F, P\u00e9rez-Montesinos G, et al. Association of Pathogenic Th17 Cells with the Disease Severity and Its Potential Implication for Biological Treatment Selection in Psoriasis Patients. Mediators Inflamm. 2020;2020:8065147.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2969_CR88","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jid.2018.07.036","volume":"139","author":"S Yu","year":"2019","unstructured":"Yu S, Wu X, Zhou Y, Han D, Anderson LS, Simon SI, et al. Is CCR6 Required for the Development of Psoriasiform Dermatitis in Mice? J Invest Dermatol. 2019;139(2):485\u20138.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2969_CR89","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/ijms17020244","volume":"17","author":"KE Kim","year":"2016","unstructured":"Kim KE, Houh Y, Park HJ, Cho D. Therapeutic Effects of Erythroid Differentiation Regulator 1 on Imiquimod-Induced Psoriasis-Like Skin Inflammation. Int J Mol Sci. 2016;17(2):244.","journal-title":"Int J Mol Sci"},{"key":"2969_CR90","doi-asserted-by":"crossref","unstructured":"Skovdahl HK, Dam\u00e5s JK, Granlund AB, \u00d8stvik AE, Doseth B, Bruland T et al. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1\u03b2 Release. Int J Mol Sci. 2018;19(10) :3257.","DOI":"10.3390\/ijms19103257"},{"issue":"3","key":"2969_CR91","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140(3):527\u201346.","journal-title":"Brain"},{"issue":"5","key":"2969_CR92","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10(5):514\u201323.","journal-title":"Nat Immunol"},{"issue":"5","key":"2969_CR93","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.4049\/jimmunol.0713169","volume":"182","author":"A Liston","year":"2009","unstructured":"Liston A, Kohler RE, Townley S, Haylock-Jacobs S, Comerford I, Caon AC, et al. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J Immunol. 2009;182(5):3121\u201330.","journal-title":"J Immunol"},{"issue":"15","key":"2969_CR94","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3748\/wjg.v16.i15.1832","volume":"16","author":"F Huang","year":"2010","unstructured":"Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol. 2010;16(15):1832\u20136.","journal-title":"World J Gastroenterol"},{"key":"2969_CR95","doi-asserted-by":"publisher","first-page":"665407","DOI":"10.3389\/fimmu.2021.665407","volume":"12","author":"T Fan","year":"2021","unstructured":"Fan T, Lu Z, Liu Y, Wang L, Tian H, Zheng Y, et al. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Front Immunol. 2021;12:665407.","journal-title":"Front Immunol"},{"issue":"1","key":"2969_CR96","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13293-021-00406-y","volume":"12","author":"T Fan","year":"2021","unstructured":"Fan T, Li C, He J. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences. Biol Sex Differ. 2021;12(1):64.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"2969_CR97","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84.","journal-title":"Breast Cancer Res"},{"key":"2969_CR98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"F Chen","year":"2015","unstructured":"Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, et al. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 2015;13:45.","journal-title":"BMC Med"},{"key":"2969_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol. 2016;39:1\u20136.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"2969_CR100","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u201373.","journal-title":"J Cancer"},{"key":"2969_CR101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1479-5876-8-45","volume":"8","author":"C Rubie","year":"2010","unstructured":"Rubie C, Frick VO, Ghadjar P, Wagner M, Grimm H, Vicinus B, et al. CCL20\/CCR6 expression profile in pancreatic cancer. J Transl Med. 2010;8:45.","journal-title":"J Transl Med"},{"issue":"6","key":"2969_CR102","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/carcin\/bgz027","volume":"40","author":"WY Huang","year":"2019","unstructured":"Huang WY, Berndt SI, Shiels MS, Katki HA, Chaturvedi AK, Wentzensen N, et al. Circulating inflammation markers and colorectal adenoma risk. Carcinogenesis. 2019;40(6):765\u201370.","journal-title":"Carcinogenesis"},{"issue":"4","key":"2969_CR103","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","volume":"21","author":"GL Beatty","year":"2015","unstructured":"Beatty GL, Gladney WL. Immune escape mechanisms as a guide for cancer immunotherapy. Clin Cancer Res. 2015;21(4):687\u201392.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2969_CR104","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"6230","key":"2969_CR105","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380.","journal-title":"Science"},{"key":"2969_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-35723-8_1","volume":"1224","author":"L Wu","year":"2020","unstructured":"Wu L, Saxena S, Singh RK. Neutrophils in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1224:1\u201320.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"2969_CR107","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","volume":"5","author":"A Ribas","year":"2015","unstructured":"Ribas A. Adaptive Immune Resistance: How Cancer Protects from Immune Attack. Cancer Discov. 2015;5(9):915\u20139.","journal-title":"Cancer Discov"},{"issue":"2","key":"2969_CR108","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, et al. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity. 2016;45(2):374\u201388.","journal-title":"Immunity"},{"issue":"5","key":"2969_CR109","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2017","unstructured":"Jim\u00e9nez-S\u00e1nchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, et al. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. Cell. 2017;170(5):927\u2013e3820.","journal-title":"Cell"},{"issue":"4","key":"2969_CR110","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017;168(4):613\u201328.","journal-title":"Cell"},{"key":"2969_CR111","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-015-0394-1","volume":"14","author":"ST Boyle","year":"2015","unstructured":"Boyle ST, Faulkner JW, McColl SR, Kochetkova M. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages. Mol Cancer. 2015;14:115.","journal-title":"Mol Cancer"},{"key":"2969_CR112","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.phrs.2015.08.004","volume":"100","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Pollard JW. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer. Pharmacol Res. 2015;100:266\u201370.","journal-title":"Pharmacol Res"},{"issue":"9","key":"2969_CR113","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559\u201372.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2969_CR114","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","volume":"21","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Wong G, Anstee QM, Henry L. The Global Burden of Liver Disease. Clin Gastroenterol Hepatol. 2023;21(8):1978\u201391.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2969_CR115","first-page":"3977","volume":"11","author":"X Yang","year":"2018","unstructured":"Yang X, Ran R, Du J, Qiu Z, Cui L, Jiang X, et al. CCL20 is overexpressed in hepatocellular carcinoma with bile duct tumor thrombus and correlates negatively with surgical outcome. Int J Clin Exp Pathol. 2018;11(8):3977\u201383.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"2969_CR116","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s11605-011-1775-4","volume":"16","author":"X Ding","year":"2012","unstructured":"Ding X, Wang K, Wang H, Zhang G, Liu Y, Yang Q, et al. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2012;16(4):828\u201336.","journal-title":"J Gastrointest Surg"},{"key":"2969_CR117","first-page":"1908","volume":"9","author":"Y Li","year":"2016","unstructured":"Li Y, Huang J, Tie H, Huang H, Li H, Ren G. Prognostic significance of CCL20 and its receptor CCR6 in cancers: a meta-analysis. Int J Clin Exp Med. 2016;9:1908\u201319.","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"2969_CR118","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.3390\/ijms15046441","volume":"15","author":"D Du","year":"2014","unstructured":"Du D, Liu Y, Qian H, Zhang B, Tang X, Zhang T, et al. The effects of the CCR6\/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma. Int J Mol Sci. 2014;15(4):6441\u201352.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2969_CR119","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41419-024-06593-x","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Qiao C, Han L, Wang X, Miao J, Cao L, et al. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20. Cell Death Dis. 2024;15(3):221.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2969_CR120","doi-asserted-by":"publisher","first-page":"e24671","DOI":"10.1371\/journal.pone.0024671","volume":"6","author":"KJ Chen","year":"2011","unstructured":"Chen KJ, Lin SZ, Zhou L, Xie HY, Zhou WH, Taki-Eldin A, et al. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS ONE. 2011;6(9):e24671.","journal-title":"PLoS ONE"},{"issue":"10","key":"2969_CR121","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41423-024-01199-x","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen W, Qiao S, Zou H, Yu XJ, Yang Y, et al. Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20\/CCR6 axis in human hepatocellular carcinoma. Cell Mol Immunol. 2024;21(10):1120\u201330.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2969_CR122","first-page":"1151","volume":"7","author":"H He","year":"2017","unstructured":"He H, Wu J, Zang M, Wang W, Chang X, Chen X, et al. CCR6(+) B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. Am J Cancer Res. 2017;7(5):1151\u201363.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"2969_CR123","first-page":"705","volume":"10","author":"D Qi","year":"2017","unstructured":"Qi D, Lin H, Gao Y, Lin J, Hu LT, Zhao GQ. The expressions of metadherin and LEF-1 in mucosa-associated lymphoid tissue lymphoma of ocular adnexal. Int J Ophthalmol. 2017;10(5):705\u201310.","journal-title":"Int J Ophthalmol"},{"issue":"16","key":"2969_CR124","first-page":"1433","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB. Prostate Cancer: Rev Jama. 2025;333(16):1433\u201346.","journal-title":"Prostate Cancer: Rev Jama"},{"issue":"11","key":"2969_CR125","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00432-008-0403-5","volume":"134","author":"P Ghadjar","year":"2008","unstructured":"Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, et al. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol. 2008;134(11):1181\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2969_CR126","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/cas.15683","volume":"114","author":"H Kano","year":"2023","unstructured":"Kano H, Izumi K, Hiratsuka K, Toriumi R, Nakagawa R, Aoyama S, et al. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis. Cancer Sci. 2023;114(4):1479\u201390.","journal-title":"Cancer Sci"},{"issue":"1","key":"2969_CR127","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-022-01630-9","volume":"21","author":"T Xie","year":"2022","unstructured":"Xie T, Fu DJ, Li ZM, Lv DJ, Song XL, Yu YZ, et al. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322\/CCL20\/CCR6 signaling. Mol Cancer. 2022;21(1):173.","journal-title":"Mol Cancer"},{"issue":"1","key":"2969_CR128","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.1038\/s41467-024-54364-1","volume":"15","author":"A Kiviaho","year":"2024","unstructured":"Kiviaho A, Eerola SK, Kallio HML, Andersen MK, Hoikka M, Tiihonen AM, et al. Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat Commun. 2024;15(1):9949.","journal-title":"Nat Commun"},{"issue":"1","key":"2969_CR129","doi-asserted-by":"publisher","first-page":"10160","DOI":"10.1038\/s41467-025-65161-9","volume":"16","author":"S Krossa","year":"2025","unstructured":"Krossa S, Andersen MK, Sandholm EM, Wess M, Kiviaho A, Sharma A, et al. Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment. Nat Commun. 2025;16(1):10160.","journal-title":"Nat Commun"},{"issue":"3","key":"2969_CR130","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2969_CR131","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2969_CR132","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2015.04.005","volume":"363","author":"GZ Wang","year":"2015","unstructured":"Wang GZ, Cheng X, Li XC, Liu YQ, Wang XQ, Shi X, et al. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer. Cancer Lett. 2015;363(1):60\u201370.","journal-title":"Cancer Lett"},{"issue":"6","key":"2969_CR133","first-page":"8183","volume":"14","author":"XP Zhang","year":"2017","unstructured":"Zhang XP, Hu ZJ, Meng AH, Duan GC, Zhao QT, Yang J. Role of CCL20\/CCR6 and the ERK signaling pathway in lung adenocarcinoma. Oncol Lett. 2017;14(6):8183\u20139.","journal-title":"Oncol Lett"},{"issue":"5","key":"2969_CR134","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jcmm.12781","volume":"20","author":"B Wang","year":"2016","unstructured":"Wang B, Shi L, Sun X, Wang L, Wang X, Chen C. Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway. J Cell Mol Med. 2016;20(5):920\u20139.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2969_CR135","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.7150\/ijbs.73275","volume":"18","author":"T Fan","year":"2022","unstructured":"Fan T, Li S, Xiao C, Tian H, Zheng Y, Liu Y, et al. CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition. Int J Biol Sci. 2022;18(11):4275\u201388.","journal-title":"Int J Biol Sci"},{"key":"2969_CR136","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biopha.2014.12.008","volume":"69","author":"CY Zhang","year":"2015","unstructured":"Zhang CY, Qi Y, Li XN, Yang Y, Liu DL, Zhao J, et al. The role of CCL20\/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients. Biomed Pharmacother. 2015;69:242\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2969_CR137","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1186\/s12967-025-06866-9","volume":"23","author":"X Hu","year":"2025","unstructured":"Hu X, Ge C, Huang C, He D, Yao X, Cheng J, et al. Enhanced homing and efficacy of HER2-CAR T cells via CXCR5\/CCR6 co-expression for HER2-positive NSCLC. J Transl Med. 2025;23(1):863.","journal-title":"J Transl Med"},{"issue":"3","key":"2969_CR138","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/sji.12087","volume":"78","author":"VO Frick","year":"2013","unstructured":"Frick VO, Rubie C, K\u00f6lsch K, Wagner M, Ghadjar P, Graeber S, et al. CCR6\/CCL20 chemokine expression profile in distinct colorectal malignancies. Scand J Immunol. 2013;78(3):298\u2013305.","journal-title":"Scand J Immunol"},{"issue":"1","key":"2969_CR139","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12967-019-2008-y","volume":"17","author":"D Wang","year":"2019","unstructured":"Wang D, Yuan W, Wang Y, Wu Q, Yang L, Li F, et al. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. J Transl Med. 2019;17(1):253.","journal-title":"J Transl Med"},{"issue":"6","key":"2969_CR140","doi-asserted-by":"publisher","first-page":"e101137","DOI":"10.1371\/journal.pone.0101137","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu J, Ke F, Xu Z, Liu Z, Zhang L, Yan S, et al. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS ONE. 2014;9(6):e101137.","journal-title":"PLoS ONE"},{"issue":"5","key":"2969_CR141","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2022.07.016","volume":"163","author":"DN Hanna","year":"2022","unstructured":"Hanna DN, Smith PM, Novitskiy SV, Washington MK, Zi J, Weaver CJ, et al. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20\/CCR6-mediated Inflammation. Gastroenterology. 2022;163(5):1334\u2013e5014.","journal-title":"Gastroenterology"},{"issue":"24","key":"2969_CR142","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.18632\/oncotarget.28131","volume":"12","author":"B Nandi","year":"2021","unstructured":"Nandi B, Del Valle JP, Samur MK, Gibbons AJ, Prabhala RH, Munshi NC, et al. CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways. Oncotarget. 2021;12(24):2323\u201337.","journal-title":"Oncotarget"},{"issue":"1","key":"2969_CR143","doi-asserted-by":"publisher","first-page":"e12186","DOI":"10.1002\/jev2.12186","volume":"11","author":"S Zhao","year":"2022","unstructured":"Zhao S, Mi Y, Zheng B, Wei P, Gu Y, Zhang Z, et al. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. J Extracell Vesicles. 2022;11(1):e12186.","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"2969_CR144","doi-asserted-by":"publisher","first-page":"e19495","DOI":"10.1371\/journal.pone.0019495","volume":"6","author":"J Liu","year":"2011","unstructured":"Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, et al. Tumor-associated macrophages recruit CCR6\u2009+\u2009regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS ONE. 2011;6(4):e19495.","journal-title":"PLoS ONE"},{"issue":"6","key":"2969_CR145","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41419-024-06806-3","volume":"15","author":"J Ouyang","year":"2024","unstructured":"Ouyang J, Hu S, Zhu Q, Li C, Kang T, Xie W, et al. RANKL\/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer. Cell Death Dis. 2024;15(6):437.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2969_CR146","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/gutjnl-2015-310016","volume":"66","author":"F Amicarella","year":"2017","unstructured":"Amicarella F, Muraro MG, Hirt C, Cremonesi E, Padovan E, Mele V, et al. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut. 2017;66(4):692\u2013704.","journal-title":"Gut"},{"issue":"3","key":"2969_CR147","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2969_CR148","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1038\/s41598-017-09040-4","volume":"7","author":"SK Lee","year":"2017","unstructured":"Lee SK, Park KK, Kim HJ, Park J, Son SH, Kim KR, et al. Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis. Sci Rep. 2017;7(1):9610.","journal-title":"Sci Rep"},{"issue":"8","key":"2969_CR149","doi-asserted-by":"publisher","first-page":"300060523117176","DOI":"10.1177\/03000605231171762","volume":"51","author":"H Zhai","year":"2023","unstructured":"Zhai H, Zhang N, Mo D, Qin T. CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer. J Int Med Res. 2023;51(8):3000605231171762.","journal-title":"J Int Med Res"},{"issue":"7","key":"2969_CR150","doi-asserted-by":"publisher","first-page":"e2005869","DOI":"10.1371\/journal.pbio.2005869","volume":"16","author":"W Chen","year":"2018","unstructured":"Chen W, Qin Y, Wang D, Zhou L, Liu Y, Chen S, et al. CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol. 2018;16(7):e2005869.","journal-title":"PLoS Biol"},{"issue":"1","key":"2969_CR151","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1080\/21655979.2021.1977102","volume":"12","author":"LB Kwantwi","year":"2021","unstructured":"Kwantwi LB, Wang S, Zhang W, Peng W, Cai Z, Sheng Y, et al. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer. Bioengineered. 2021;12(1):6996\u20137006.","journal-title":"Bioengineered"},{"issue":"1","key":"2969_CR152","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","volume":"8","author":"R Zhang","year":"2023","unstructured":"Zhang R, Dong M, Tu J, Li F, Deng Q, Xu J, et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct Target Ther. 2023;8(1):97.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"2969_CR153","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal Cell Carcinoma: A Review. JAMA. 2024;332(12):1001\u201310.","journal-title":"JAMA"},{"issue":"2","key":"2969_CR154","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.eururo.2011.10.035","volume":"61","author":"KA Oldham","year":"2012","unstructured":"Oldham KA, Parsonage G, Bhatt RI, Wallace DM, Deshmukh N, Chaudhri S, et al. T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6. Eur Urol. 2012;61(2):385\u201394.","journal-title":"Eur Urol"},{"key":"2969_CR155","doi-asserted-by":"crossref","unstructured":"Kadomoto S, Izumi K, Hiratsuka K, Nakano T, Naito R, Makino T et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis. Cancers (Basel). 2019;12(1 ):89 .","DOI":"10.3390\/cancers12010089"},{"issue":"5","key":"2969_CR156","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","volume":"39","author":"DA Braun","year":"2021","unstructured":"Braun DA, Street K, Burke KP, Cookmeyer DL, Denize T, Pedersen CB, et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell. 2021;39(5):632\u2013e488.","journal-title":"Cancer Cell"},{"key":"2969_CR157","doi-asserted-by":"crossref","unstructured":"Song X, Zhu Y, Geng W, Jiao J, Liu H, Chen R et al. Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. J Immunother Cancer. 2025;13(1) :e010183.","DOI":"10.1136\/jitc-2024-010183"},{"issue":"5","key":"2969_CR158","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338\u201349.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2969_CR159","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cyto.2015.05.009","volume":"76","author":"G Han","year":"2015","unstructured":"Han G, Wu D, Yang Y, Li Z, Zhang J, Li C. CrkL meditates CCL20\/CCR6-induced EMT in gastric cancer. Cytokine. 2015;76(2):163\u20139.","journal-title":"Cytokine"},{"key":"2969_CR160","doi-asserted-by":"publisher","first-page":"e19477","DOI":"10.7717\/peerj.19477","volume":"13","author":"L Liu","year":"2025","unstructured":"Liu L, Xiong L, Peng H, Deng Q, Liu K, Xia S. BNC1 inhibits the development and progression of gastric cancer by regulating the CCL20\/JAK-STAT axis. PeerJ. 2025;13:e19477.","journal-title":"PeerJ"},{"issue":"6","key":"2969_CR161","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s10120-023-01418-w","volume":"26","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wei D, Deguchi Y, Xu W, Tian R, Liu F, et al. PPAR\u03b4 dysregulation of CCL20\/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment. Gastric Cancer. 2023;26(6):904\u201317.","journal-title":"Gastric Cancer"},{"key":"2969_CR162","doi-asserted-by":"crossref","unstructured":"Maddipati R. Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention. J Clin Invest. 2025;135(14) :e191943.","DOI":"10.1172\/JCI191943"},{"issue":"5","key":"2969_CR163","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.bbamcr.2017.02.005","volume":"1864","author":"C Geismann","year":"2017","unstructured":"Geismann C, Grohmann F, Dreher A, H\u00e4sler R, Rosenstiel P, Legler K, et al. Role of CCL20 mediated immune cell recruitment in NF-\u03baB mediated TRAIL resistance of pancreatic cancer. Biochim Biophys Acta Mol Cell Res. 2017;1864(5):782\u201396.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2969_CR164","doi-asserted-by":"publisher","first-page":"1216376","DOI":"10.3389\/fimmu.2023.1216376","volume":"14","author":"M Wu","year":"2023","unstructured":"Wu M, Han J, Wu H, Liu Z. Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma. Front Immunol. 2023;14:1216376.","journal-title":"Front Immunol"},{"issue":"1","key":"2969_CR165","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12964-024-01578-x","volume":"22","author":"H Li","year":"2024","unstructured":"Li H, Ruan Y, Liu C, Fan X, Yao Y, Dai Y, et al. VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage. Cell Commun Signal. 2024;22(1):224.","journal-title":"Cell Commun Signal"},{"key":"2969_CR166","doi-asserted-by":"crossref","unstructured":"Brunner PM, Koszik F, Reininger B, Kalb ML, Bauer W, Stingl G. Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages. J Allergy Clin Immunol. 2013;132(5).","DOI":"10.1016\/j.jaci.2013.05.036"},{"issue":"8","key":"2969_CR167","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamadermatol.2015.0452","volume":"151","author":"AM Goldminz","year":"2015","unstructured":"Goldminz AM, Su\u00e1rez-Fari\u00f1as M, Wang AC, Dumont N, Krueger JG, Gottlieb AB. CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial. JAMA Dermatol. 2015;151(8):837\u201346.","journal-title":"JAMA Dermatol"},{"key":"2969_CR168","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/jci.insight.94821","volume":"2","author":"R Robert","year":"2017","unstructured":"Robert R, Ang C, Sun G, Juglair L, Lim EX, Mason LJ, et al. Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice. JCI Insight. 2017;2:15.","journal-title":"JCI Insight"},{"issue":"1","key":"2969_CR169","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/jid.2012.260","volume":"133","author":"T Mabuchi","year":"2013","unstructured":"Mabuchi T, Singh TP, Takekoshi T, Jia G-F, Wu X, Kao MC, et al. CCR6 is required for epidermal trafficking of \u03b3\u03b4-T cells in an IL-23-induced model of psoriasiform dermatitis. J Invest Dermatol. 2013;133(1):164\u201371.","journal-title":"J Invest Dermatol"},{"issue":"47","key":"2969_CR170","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1073\/pnas.1704958114","volume":"114","author":"AE Getschman","year":"2017","unstructured":"Getschman AE, Imai Y, Larsen O, Peterson FC, Wu X, Rosenkilde MM, et al. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model. Proc Natl Acad Sci U S A. 2017;114(47):12460\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2969_CR171","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1111\/bcp.13286","volume":"83","author":"G Bouma","year":"2017","unstructured":"Bouma G, Zamuner S, Hicks K, Want A, Oliveira J, Choudhury A, et al. CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6\u2009+\u2009cells in an experimental suction blister. Br J Clin Pharmacol. 2017;83(9):1976\u201390.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"2969_CR172","doi-asserted-by":"publisher","first-page":"G1263","DOI":"10.1152\/ajpgi.00409.2006","volume":"292","author":"K Katchar","year":"2007","unstructured":"Katchar K, Kelly CP, Keates S, O\u2019Brien MJ, Keates AC. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am J Physiol Gastrointest Liver Physiol. 2007;292(5):G1263\u201371.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"2969_CR173","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.4049\/jimmunol.170.12.6298","volume":"170","author":"RE Kohler","year":"2003","unstructured":"Kohler RE, Caon AC, Willenborg DO, Clark-Lewis I, McColl SR. A role for macrophage inflammatory protein-3 alpha\/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J Immunol. 2003;170(12):6298\u2013306.","journal-title":"J Immunol"},{"issue":"6","key":"2969_CR174","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/00130404-200411000-00007","volume":"10","author":"TF Kimsey","year":"2004","unstructured":"Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J. 2004;10(6):374\u201380.","journal-title":"Cancer J"},{"issue":"25","key":"2969_CR175","doi-asserted-by":"publisher","first-page":"11535","DOI":"10.7150\/thno.45261","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y, et al. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma. Theranostics. 2020;10(25):11535\u201348.","journal-title":"Theranostics"},{"issue":"16","key":"2969_CR176","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1158\/0008-5472.CAN-08-0402","volume":"68","author":"N Giuliani","year":"2008","unstructured":"Giuliani N, Lisignoli G, Colla S, Lazzaretti M, Storti P, Mancini C, et al. CC-chemokine ligand 20\/macrophage inflammatory protein-3\u03b1 and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Cancer Res. 2008;68(16):6840\u201350.","journal-title":"Cancer Res"},{"issue":"5","key":"2969_CR177","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00262-022-03313-2","volume":"72","author":"C Rutihinda","year":"2023","unstructured":"Rutihinda C, Haroun R, Saidi NE, Ordo\u00f1ez JP, Naasri S, L\u00e9vesque D, et al. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy. Cancer Immunol Immunother. 2023;72(5):1089\u2013102.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2969_CR178","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1128\/jvi.39.1.318-320.1981","volume":"39","author":"R Marrero","year":"1981","unstructured":"Marrero R, Chiafari FA, Lovett PS. High-frequency elimination of SP02 prophage from Bacillus subtilis by plasmid transformation. J Virol. 1981;39(1):318\u201320.","journal-title":"J Virol"},{"issue":"10","key":"2969_CR179","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2013-09-527739","volume":"123","author":"M Ito","year":"2014","unstructured":"Ito M, Teshima K, Ikeda S, Kitadate A, Watanabe A, Nara M, et al. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma. Blood. 2014;123(10):1499\u2013511.","journal-title":"Blood"},{"issue":"8","key":"2969_CR180","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.scib.2020.12.027","volume":"66","author":"L Jin","year":"2021","unstructured":"Jin L, Cao L, Zhu Y, Cao J, Li X, Zhou J, et al. Enhance anti-lung tumor efficacy of chimeric antigen receptor-T cells by ectopic expression of C-C motif chemokine receptor 6. Sci Bull (Beijing). 2021;66(8):803\u201312.","journal-title":"Sci Bull (Beijing)"},{"key":"2969_CR181","doi-asserted-by":"crossref","unstructured":"Wang J, Wang Y, Pan H, Zhao L, Yang X, Liang Z et al. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. Int J Mol Sci. 2023;24(6) :5424.","DOI":"10.3390\/ijms24065424"},{"issue":"7326","key":"2969_CR182","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09626","volume":"468","author":"R Nazarian","year":"2010","unstructured":"Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 2010;468(7326):973\u20137.","journal-title":"Nature"},{"issue":"11","key":"2969_CR183","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1200\/JCO.2008.17.5844","volume":"27","author":"M Di Maio","year":"2009","unstructured":"Di Maio M, Chiodini P, Georgoulias V, Hatzidaki D, Takeda K, Wachters FM, et al. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol. 2009;27(11):1836\u201343.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2969_CR184","doi-asserted-by":"publisher","first-page":"10665","DOI":"10.1007\/s13277-016-4902-8","volume":"37","author":"J Kumbrink","year":"2016","unstructured":"Kumbrink J, de la Cueva A, Soni S, Sailer N, Kirsch KH. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo. Tumour Biol. 2016;37(8):10665\u201373.","journal-title":"Tumour Biol"},{"issue":"3","key":"2969_CR185","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/carcin\/bgs384","volume":"34","author":"J Li","year":"2013","unstructured":"Li J, Zhang L, Zhang J, Wei Y, Li K, Huang L, et al. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Carcinogenesis. 2013;34(3):658\u201366.","journal-title":"Carcinogenesis"},{"key":"2969_CR186","doi-asserted-by":"publisher","first-page":"1440830","DOI":"10.3389\/fimmu.2024.1440830","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yu M, Zhang S. The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies. Front Immunol. 2024;15:1440830.","journal-title":"Front Immunol"},{"issue":"9\u201310","key":"2969_CR187","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/jocn.12736","volume":"24","author":"BA Ewens","year":"2015","unstructured":"Ewens BA, Hendricks JM, Sundin D. The use, prevalence and potential benefits of a diary as a therapeutic intervention\/tool to aid recovery following critical illness in intensive care: a literature review. J Clin Nurs. 2015;24(9\u201310):1406\u201325.","journal-title":"J Clin Nurs"},{"issue":"1","key":"2969_CR188","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41419-025-08359-5","volume":"17","author":"S Zhang","year":"2025","unstructured":"Zhang S, Liu H, Li X, Jiang Y, Tang L, Liu T, et al. CCL20 secreted by KRT15(high) tumor Cells promotes tertiary lymphoid structure formation and enhances anti-PD-1 therapy response in HPV(+)HNSCC. Cell Death Dis. 2025;17(1):150.","journal-title":"Cell Death Dis"},{"key":"2969_CR189","doi-asserted-by":"crossref","unstructured":"Robert R, Ang C, Sun G, Juglair L, Lim EX, Mason LJ, et al. Essential role for CCR6 in certain inflammatorydiseases demonstrated using specific antagonist and knockin mice. JCI Insight. 2017;2(15).","DOI":"10.1172\/jci.insight.94821"},{"key":"2969_CR190","doi-asserted-by":"crossref","unstructured":"Mabuchi T, Singh TP, Takekoshi T, Jia GF, Wu X,Kao MC, et al. CCR6 is required for epidermal trafficking of \u03b3\u03b4-T cells in an IL-23-induced model of psoriasiform dermatitis. J Invest Dermatol.2013;133(1):164\u201371.","DOI":"10.1038\/jid.2012.260"},{"key":"2969_CR191","doi-asserted-by":"crossref","unstructured":"Getschman AE, Imai Y, Larsen O, Peterson FC, Wu X, Rosenkilde MM, et al. Protein engineering of the chemokineCCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model. Proc Natl Acad Sci U S A. 2017;114(47):12460\u20135.","DOI":"10.1073\/pnas.1704958114"},{"key":"2969_CR192","doi-asserted-by":"crossref","unstructured":"Bouma G,Zamuner S, Hicks K, Want A, Oliveira J, Choudhury A, et al. CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6(+) cells in an experimental suction blister. Br J Clin Pharmacol. 2017;83(9):1976\u201390.","DOI":"10.1111\/bcp.13286"},{"key":"2969_CR193","doi-asserted-by":"crossref","unstructured":"Katchar K, Kelly CP, Keates S,O'Brien M J, Keates AC. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. AmJ Physiol Gastrointest Liver Physiol. 2007;292(5):G1263\u201371.","DOI":"10.1152\/ajpgi.00409.2006"},{"key":"2969_CR194","doi-asserted-by":"crossref","unstructured":"Arima Y, Harada M, Kamimura D, Park JH, Kawano F, Yull FE, et al. Regionalneural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell. 2012;148(3):447\u201357.","DOI":"10.1016\/j.cell.2012.01.022"},{"key":"2969_CR198","doi-asserted-by":"crossref","unstructured":"Kimsey TF, CampbellAS, Albo D, Wilson M, Wang TN. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotespancreatic cancer cell invasion. Cancer J. 2004;10(6):374\u201380.","DOI":"10.1097\/00130404-200411000-00007"},{"key":"2969_CR196","doi-asserted-by":"crossref","unstructured":"Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y, et al. FOXO1 promotes tumorprogression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma. Theranostics. 2020;10(25):11535\u201348.","DOI":"10.7150\/thno.45261"},{"key":"2969_CR197","doi-asserted-by":"crossref","unstructured":"Giuliani N, Lisignoli G, Colla S, Lazzaretti M, Storti P, Mancini C, et al. CC-chemokine ligand 20\/macrophage inflammatory protein-3\u03b1 and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Cancer Res. 2008;68(16):6840\u201350.","DOI":"10.1158\/0008-5472.CAN-08-0402"},{"key":"2969_CR199","doi-asserted-by":"crossref","unstructured":"Rutihinda C, Haroun R, Saidi NE, Ordo\u00f1\u00f1ez JP, Naasri S, L\u00e9\u00e9vesque D, et al. Inhibition of the CCR6-CCL20 axis prevents regulatory T cellrecruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy. Cancer Immunol Immunother. 2023;72(5):1089\u2013102.","DOI":"10.1007\/s00262-022-03313-2"},{"key":"2969_CR200","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhou P, Deng Y, Cai X, Sun M, Sun Y, et al. ALKBH5-mediated m(6) A demethylation of TIRAP mRNA promotes radiation-induced liverfibrosis and decreases radiosensitivity of hepatocellular carcinoma. Clin Transl Med. 2023;13(2):e1198.","DOI":"10.1002\/ctm2.1198"},{"key":"2969_CR201","doi-asserted-by":"crossref","unstructured":"Ito M, Teshima K, Ikeda S, Kitadate A, Watanabe A, Nara M, et al. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma. Blood. 2014;123(10):1499\u2013511.","DOI":"10.1182\/blood-2013-09-527739"},{"key":"2969_CR202","doi-asserted-by":"crossref","unstructured":"Wang J, Wang Y, Pan H, Zhao L, Yang X, Liang Z, et al. Chemokine ReceptorsCCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. Int J Mol Sci. 2023;24(6).","DOI":"10.3390\/ijms24065424"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02969-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:02:20Z","timestamp":1787889740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02969-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":201,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02969-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"463"}}